Wanbury has received a term loan facilities of Rs 60 crore from Tata Capital, Mumbai at 12.50% interest per annum repayable over a period of seven years. The funds received by the company will be utilized towards the long-term working capital and capex requirement.
Wanbury, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 Companies’ in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation.